Others (262) Publications in which a researcher has participated View referenced research data.

filter_list Type (aggr.) Others

2024

  1. Actividad Física, Ejercicio y Salud: Retos Actuales y Desafíos Futuros

    Revista Andaluza de Medicina del Deporte

  2. Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)

    Journal of the European Academy of Dermatology and Venereology

  3. Bilateral primary motor area intermittent theta-burst stimulation may alleviate gait and postural disturbances in Parkinson's disease patients by astrocytic modulation, caudate volume changes, and increased functional neuroplasticity

    Parkinsonism and Related Disorders

  4. Correction to: Association between co-sleeping in the first year of life and preschoolers´ sleep patterns(European Journal of Pediatrics, 10.1007/s00431-024-05429-2)

    European Journal of Pediatrics

  5. Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis (Dermatology and Therapy, (2024), 14, 1, (169-182), 10.1007/s13555-023-01058-z)

    Dermatology and Therapy

  6. Corrigendum: Health-related quality of life in children born preterm at school age: the mediating role of social support and maternal stress (Frontiers in Psychology, (2024), 15, (1463804), 10.3389/fpsyg.2024.1463804)

    Frontiers in Psychology

  7. Editorial: Editors showcase 2023: insights in stem cell research

    Frontiers in Cell and Developmental Biology

  8. In vitro susceptibility to delafloxacin of Pseudomonas aeruginosa with resistance to other quinolones (ciprofloxacin and levofloxacin)

    Clinical Microbiology and Infection

  9. Low back pain: advancements and challenges in its prevention and management

    Archivos de Medicina del Deporte

  10. Optimal timing of antibiotic administration in septic patients: The need to reformulate this question

    European Journal of Internal Medicine

  11. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  12. Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”

    Dermatology and Therapy

  13. The Positioning of Ceftobiprole in Staphylococcus aureus Bacteremia

    Clinical Infectious Diseases